A Combined Lymphokine-activated Killer (LAK) cell immunotherapy and adenovirus-p53 gene therapy for head and neck squamous cell carcinoma

Hiroki Saito, Satoshi Ando, Naoya Morishita, Kyung Mi Lee, Dante Dator, David Dy, Katsumi Shigemura, Zainal Adhim, Ken Ichi Nibu, Masato Fujisawa, Toshiro Shirakawa

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'A Combined Lymphokine-activated Killer (LAK) cell immunotherapy and adenovirus-p53 gene therapy for head and neck squamous cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences